Suppression of low dose streptozotocin induced diabetes in mice by administration of a nitric oxide synthase inhibitor

This publication has 12 references indexed in Scilit:

• Molecular basis of "suppressor" macrophages. Arginine metabolism via the nitric oxide synthetase pathway.
  The Journal of Immunology, 1991
• Activated macrophages kill pancreatic syngeneic islet cells via arginine-dependent nitric oxide generation
  Biochemical and Biophysical Research Communications, 1991
• Inhibition of insulin secretion by interleukin‐1β and tumour necrosis factor‐α via an L‐arginine‐dependent nitric oxide generating mechanism
  FEBS Letters, 1990
• Regional haemodynamic changes during oral ingestion of N^G‐monomethyl‐l‐arginine or N^G‐nitro‐l‐arginine methyl ester in conscious Brattleboro rats
  British Journal of Pharmacology, 1990
• Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells.
  The Journal of Experimental Medicine, 1989
• NG-methylarginine, and inhibitor of endothelium-derived nitric oxide synthesis, is a potent pressor agent in the guinea pig: Does nitric oxide regulate blood pressure in vivo?
  Biochemical and Biophysical Research Communications, 1989
• Low-dose streptozocin-induced diabetes in mice. Electron microscopy reveals single-cell insulitis before diabetes onset
  Diabetes, 1988
• Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
  Nature, 1987
• Surface properties of bacillus Calmette-Guérin-activated mouse macrophages. Reduced expression of mannose-specific endocytosis, Fc receptors, and antigen F4/80 accompanies induction of Ia.
  The Journal of Experimental Medicine, 1981
• Mac‐1: a macrophage differentiation antigen identified by monoclonal antibody
  European Journal of Immunology, 1979